Pharming Group N.V.

    Jurisdiction
    Netherlands
    LEI
    724500DCJ9MPG74JEH91
    ISIN
    NL0010391025 (PHARM.AS)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    6 / 7

    Profile

    Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €291.76M
    Gross margin
    89.3%
    EBIT
    €12.54M
    EBIT margin
    4.3%
    Net income
    -€7.04M
    Net margin
    -2.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €315.21M +8.0% €19.14M -372.0%
    €349.20M +10.8% €42.10M +120.0%
    €313.05M -10.4% €53.80M +27.8%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: August 1, 2025

    Add to watchlist

    Notifications